spite of the frequently ambiguous identification of metabolites due to the lack of reference compounds and intrinsic limitations of mass spectrometry (MS) data interpretation, this technology facilitates new insights into currently unexplored metabolic pathways (Mintz-Oron et al., 2008; Hall and Hardy, 2012) . The powerful feature of metabolomics is in its ability to perform non-targeted analysis, which permits the detection and to a certain extent identification of "unexpected" metabolites that were not initially "under the spotlight".
The development of metabolomics approaches was largely driven by quantum leaps in analytical chemistry tools that allow for the separation and detection of metabolites (Allwood et al., 2011) . The most widespread technology used currently in metabolomics assays is Liquid Chromatography -MS (LC-MS) (Lei et al., 2011; Moing et al., 2011) . Instruments with rapid and high-resolution separation capacity through ultra-pressure chromatography are typically coupled with MS detectors with extreme resolution and accurate mass determination capabilities. Complementary technologies include Gas Chromatography MS (GC-MS) (Almstetter et al., 2012) , and Nuclear Magnetic Resonance (Kim et al., 2011; Ward et al., 2011) . Another key feature of these cutting-edge analytical tools is their versatility in examining any given extract from bacteria to fungi, plants and mammalian cells. Nevertheless, to date no extraction method nor any technological platform exists that enables the measurement of all endogenous metabolites in a single extract.
Plants are especially appropriate targets for metabolomics approaches because they produce a wide range of metabolites (Clardy and Walsh, 2004) . Several of these metabolites belong to unique chemical classes, and are of great importance in our diet and daily life. The most widespread use of metabolomics technologies is currently in functional genomics, which links genetic and metabolic changes (Fiehn et al., 2000) . This can be observed in the influence of abiotic/biotic stresses on metabolism (Obata and Fernie, 2012) , or as an analysis tool employed in metabolic engineering approaches (Wu and Chappell, 2008) . Furthermore, metabolomics becomes an integral part of systems biology where changes at the metabolome, transcriptome and/or proteome levels are analyzed in an integrated fashion (as exemplified by (Liberman et al., 2012) . Recent advancements in the isolation of individual cell populations (e.g. through laser capture micro-dissection and fluorescence-activated cell sorting) can now be coupled to metabolomics analysis for a comprehensive investigation of the time-and space-resolved distribution of analytes (Rogers et al., 2012) . Finally given that metabolism is highly compartmentalized, more and more attention is paid also to the study of metabolism at a subcellular level (Krueger et al., 2011) .
Combining metabolomics with chemical genomics, also referred to as "ChemoMetabolomics" is a promising future application of both technologies. In such experiments, samples derived from cell cultures or whole organisms that were treated with a library of chemicals would be subjected to metabolomics analyses, as for example those employing high-resolution mass spectrometry instruments. As compared to genetic approaches, "ChemoMetabolomics", as well as chemical genomics, has the advantage of a timeresolved conditional disturbance, whereby the samples are exposed to a given chemical treatment over different time periods. This allows for the identification of perturbations, which when constitutively active (i.e. in a mutant) are lethal and thus not accessible for analysis. Examination of the metabolic response of the biological system to the chemical treatment can result in a number of potential outcomes (Fig. 1) . A first obvious one is the identification of lead compounds that represent a starting point for the development of highly potent inhibitors, or modulators, of a metabolic pathway. Depending on the intermediate metabolites that can be identified in a given pathway, it might even be possible to predict the target protein/enzyme due to the specific change of metabolites in this putative pathway. Furthermore, while established target-oriented high-throughput setups that use in vitro systems monitor only one enzymatic reaction per experiment, the proposed approach facilitates screening products of many enzymatic reactions at a time. Moreover, a predicted change in the metabolic profile upon chemical treatment can be used to identify a chemical that targets a given enzyme. Leads identified in this way may be useful as inhibitors, blocking or enhancing certain specific biochemical pathways (e.g. resulting in the discovery of new herbicides, or of compound that boost a biosynthetic pathway of interest). A second, and more complex outcome is the reconstruction of metabolic networks based on the perturbation data obtained using a large number of chemicals. Once a chemical affecting multiple metabolic pathways is identified, this will open the way to dissect the exceedingly intricate crosstalk in the metabolic network. A third obvious outcome is based on the integrated analysis of metabolic changes and corresponding alterations in developmental or cellular processes, thus allowing to develop a hypothesis regarding the effect of changes in metabolism on developmental or cellular responses. Consequently, applying chemicals that could perturb vesicular-based metabolite trafficking will enable new insights into where and how metabolites are delivered to their site of action and/or storage.
While carrying out metabolomics assays undoubtedly has multiple advantages, largely due to the quantity and diversity of metabolite coverage and the "un-targeted approach", it might not always be the preferred method for metabolite analysis. As in other technologies, increasing metabolite coverage decreases capabilities in terms of sensitivity and quantification (Sweetlove et al., 2003) . Moreover, the capacity to accurately and unambiguously identify metabolites is reduced to a great extent (Fernie et al., 2011) . In some cases a particular section of the metabolic network consisting of several metabolites that are structurally or functionally/biologically related (e.g. carotenoids, vitamins, hormones and amino acids) are of interest. In this view, one might choose to utilize in "ChemoMetabolomics" the "metabolite profiling" approach in which defined, well-established procedures are used to extract, separate, detect, quantify and identify the metabolites in a "targeted" manner (Gu et al., 2012) .
An important part of data handling and quality control procedures includes attempts to identify the metabolic "fate" of the chemical used for treatment and subsequently filtering out its derivatives that in most cases form through endogenous metabolism and can be the primary cause of the metabolic phenotype observed. A next step in "ChemoMetabolomics" would consist of genetic screens to isolate mutants that are hypersensitive or resistant to the chemical of interest, which will facilitate the location of the component(s)/target(s). Another approach for identifying targets is analyzing the similarity between metabolic profiles obtained from genetic mutants to those obtained from "ChemoMetabolomics", which will also allow the identification of the target protein and pathway of a given chemical. The output of such experiments could also be integrated and mutually queried with additional data derived from various chemical screens at the developmental and cell biological levels. The generation and mining of such a compendium of datasets could be an excellent instrument to probe yet undiscovered links between metabolic and developmental programs and to obtain a more detailed view of biological processes at the system level. Our labs have just recently initiated "ChemoMetabolomics" experiments with the most encouraging preliminary data. It is expected that once established this concept will open new frontiers in metabolic studies by leveraging on the gradually vanishing boundary between chemistry and biology. 
